Acadia Healthcare Co Inc

Acadia Healthcare Co Inc Stock Forecast & Price Prediction

Live Acadia Healthcare Co Inc Stock (ACHC) Price
$40.82

17

Ratings

  • Buy 10
  • Hold 7
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$40.82

P/E Ratio

13.79

Volume Traded Today

$982,900

Dividend

Dividends not available for ACHC

52 Week High/low

87.77/40.79

Acadia Healthcare Co Inc Market Cap

$3.91B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $ACHC ๐Ÿ›‘

Before you buy ACHC you'll want to see this list of ten stocks that have huge potential. Want to see if ACHC made the cut? Enter your email below

ACHC Summary

Based on ratings from 17 stock analysts, the Acadia Healthcare Co Inc stock price is expected to increase by 63.11% in 12 months. This is calculated by using the average 12-month stock price forecast for Acadia Healthcare Co Inc. The lowest target is $45 and the highest is $94. Please note analyst price targets are not guaranteed and could be missed completely.

ACHC Analyst Ratings

About 17 Wall Street analysts have assignedACHC 10 buy ratings, 7 hold ratings, and 0 sell ratings. This means that analysts expect Acadia Healthcare Co Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ACHC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

ACHC stock forecast by analyst

These are the latest 20 analyst ratings of ACHC.

Analyst/Firm

Rating

Price Target

Change

Date

Matthew Gillmor
Keybanc

Sector Weight


Initiates

Oct 11, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Oct 4, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Oct 1, 2024
Andrew Mok
Barclays

Overweight

$76

Maintains

Sep 30, 2024
Ben Hendrix
RBC Capital

Outperform

$94

Reiterates

Sep 20, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Aug 20, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Aug 19, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Aug 2, 2024
Pito Chickering
Deutsche Bank

Hold

$75

Maintains

Aug 2, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Aug 1, 2024
Andrew Mok
Barclays

Overweight

$83

Maintains

Aug 1, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Jul 10, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Jul 9, 2024
Sarah James
Cantor Fitzgerald

Neutral

$90

Reiterates

Jul 2, 2024
Ben Hendrix
RBC Capital

Outperform

$94

Reiterates

May 22, 2024
Gary Taylor
TD Cowen

Buy

$91

Maintains

May 17, 2024
Andrew Mok
Barclays

Overweight

$89

Maintains

May 15, 2024
Ann Hynes
Mizuho

Neutral

$70

Maintains

May 3, 2024
Andrew Mok
Barclays

Overweight

$91

Maintains

May 2, 2024
Kevin Fischbeck
B of A Securities

Buy

$90

Maintains

May 2, 2024

ACHC Company Information

What They Do: Provides behavioral healthcare services.

Business Model: The company operates a range of facilities including acute inpatient psychiatric hospitals, specialty treatment centers, and outpatient services, generating revenue through patient admissions and treatment programs. Its diverse offerings cater to various behavioral health needs, positioning it as a key player in the healthcare sector.

Other Information: Founded in 2005 and headquartered in Franklin, Tennessee, the company serves communities across the United States and Puerto Rico, focusing on comprehensive recovery solutions for mental health and addiction issues.
ACHC
Acadia Healthcare Co Inc (ACHC)

When did it IPO

1994

Staff Count

17,000

Country

United States

Sector/Industry

Healthcare/Medical Care Facilities

CEO

Mr. Christopher Howal Hunter

Market Cap

$3.91B

Acadia Healthcare Co Inc (ACHC) Financial Data

In 2023, ACHC generated $2.93B in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ACHC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

$2.93B

0.00 %
From Previous Year
  • Revenue TTM $3.12B
  • Operating Margin TTM 18.0%
  • Gross profit TTM $2.82B
  • Return on assets TTM 6.1%
  • Return on equity TTM 9.8%
  • Profit Margin 9.0%
  • Book Value Per Share 33.04%
  • Market capitalisation $3.91B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 $2.93B
  • EPS this year (TTM) $2.96

Acadia Healthcare Co Inc (ACHC) Latest News

News Image

Fri, 08 Nov 2024

Sentiment - NEUTRAL

Source - GlobeNewsWire

Summary - A class action lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and some of its officers, as announced by Bronstein, Gewirtz & Grossman, LLC.

Why It Matters - A class action lawsuit against Acadia Healthcare could lead to financial liabilities and reputational damage, potentially impacting stock performance and investor confidence.

News Image

Fri, 08 Nov 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Investors in Acadia Healthcare Company (NasdaqGS: ACHC) who purchased securities from Feb 28, 2020, to Oct 18, 2024, have until Dec 16, 2024, to file lead plaintiff applications in a class action lawsuit.

Why It Matters - The class action lawsuit against Acadia Healthcare may impact investor sentiment and stock price, especially for those who purchased shares during the specified period.

News Image

Fri, 08 Nov 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Acadia Healthcare Company, Inc. (NASDAQ: ACHC) faces a class action lawsuit. Investors who purchased shares between Feb 28, 2020, and Sept 26, 2024, can apply to be lead plaintiff by Dec 16, 2024.

Why It Matters - The announcement of a class action lawsuit against Acadia Healthcare could lead to increased volatility in its stock price, impacting investor sentiment and potential returns.

News Image

Thu, 07 Nov 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - A class action lawsuit has been filed against Acadia Healthcare (NASDAQ: ACHC) for alleged federal securities law violations, affecting investors from February 28, 2020, to October 18, 2024.

Why It Matters - A class action lawsuit against Acadia Healthcare for alleged securities law violations could impact stock performance, investor confidence, and potential financial liabilities for the company.

News Image

Fri, 08 Nov 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - A class action lawsuit has been filed against Acadia Healthcare (NASDAQ: ACHC) for alleged federal securities law violations, covering investors from February 28, 2020, to October 18, 2024.

Why It Matters - A class action lawsuit against Acadia Healthcare may lead to financial liabilities and regulatory scrutiny, potentially impacting stock performance and investor confidence.

News Image

Fri, 08 Nov 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - A class action lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ: ACHC). Investors can contact Pomerantz LLP for more information.

Why It Matters - A class action lawsuit against Acadia Healthcare may signal potential legal and financial risks, impacting stock performance and investor sentiment.

...

ACHC Frequently asked questions

The highest forecasted price for ACHC is $94 from Frank Morgan at RBC Capital.

The lowest forecasted price for ACHC is $45 from Joseph France from Cantor Fitzgerald

The ACHC analyst ratings consensus are 10 buy ratings, 7 hold ratings, and 0 sell ratings.